|
⚲
|
| Keyboard |
| Clifford Stocks | |
|---|---|
| Firm | |
| Address | 609 Main Street Suite 4200 Houston, TX 77002 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Oncoresponse Inc | 021-545368 | Director | 6.0 M | ||
| Immunogenesis Inc | 021-535325 | Director | 5.7 M of 25.0 M |
||
| Immunogenesis Inc | 021-509426 | Director | 44.4 M of 66.5 M |
||
| K2 Biolabs Inc | 021-488578 | Director | 0.6 M of 3.0 M |
||
| Oncoresponse Inc | 021-481584 | Executive Officer | 13.9 M of 40.0 M |
||
| Oncoresponse Inc | 021-394093 | Executive Officer | 40.6 M of 60.0 M |
||
| K2 Biolabs LLC | 021-392132 | Director | 5.5 M of 5.5 M |
||
| Cardiac Insight Inc | 021-346573 | Director | 4.7 M of 11.8 M |
||
| Oncoresponse Inc | 021-320707 | Executive Officer | 19.0 M of 40.0 M |
||
| Oncoresponse Inc | 021-249440 | Executive Officer | 29.5 M of 34.0 M |
||
| Theraclone Sciences Inc | 021-239360 | Executive Officer | 3.1 M of 4.4 M |
||
| Theraclone Sciences Inc | 021-200360 | Executive Officer | 6.0 M of 6.4 M |
||
| Theraclone Sciences Inc | 021-193896 | Executive Officer | 4.0 M of 8.0 M |
||
| Calistoga Pharmaceuticals Inc | 021-144409 | Executive Officer | 25.0 M of 50.0 M |
||